Trimetazidine in Chronic Coronary Syndrome and Coronary Artery Disease: A Narrative Review of Clinical Efficacy, Safety, and Current Guideline Position

Daniel Miron Brie, Cristian Mornoș, Alexandru Tîrziu, Roxana Popescu, Alina Diduța Brie

Open source

DOI
10.3390/ph19091370
Published
2026-08-29
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091370,
  title = {Trimetazidine in Chronic Coronary Syndrome and Coronary Artery Disease: A Narrative Review of Clinical Efficacy, Safety, and Current Guideline Position},
  author = {Daniel Miron Brie and Cristian Mornoș and Alexandru Tîrziu and Roxana Popescu and Alina Diduța Brie},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19091370},
  url = {https://doi.org/10.3390/ph19091370}
}

RIS

TY  - JOUR
TI  - Trimetazidine in Chronic Coronary Syndrome and Coronary Artery Disease: A Narrative Review of Clinical Efficacy, Safety, and Current Guideline Position
AU  - Daniel Miron Brie
AU  - Cristian Mornoș
AU  - Alexandru Tîrziu
AU  - Roxana Popescu
AU  - Alina Diduța Brie
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19091370
UR  - https://doi.org/10.3390/ph19091370
ER  - 

APA

Brie, D. M., Mornoș, C., Tîrziu, A., Popescu, R., & Brie, A. D. (2026). Trimetazidine in Chronic Coronary Syndrome and Coronary Artery Disease: A Narrative Review of Clinical Efficacy, Safety, and Current Guideline Position. Pharmaceuticals. https://doi.org/10.3390/ph19091370

Source records